For patients with recurrent retroperitoneal sarcomas that cannot be treated surgically, treatment choices are limited. These tumors can grow quite large in the abdomen adjacent to vital organs or ...

Early-stage prostate cancer rarely causes symptoms, making routine screening the most reliable way to catch it before it ...

Mary Bird Perkins Cancer Center is launching a $10 million adaptive radiation therapy program that uses a technology designed in Sweden to enhance the precision of radiation doses, the organization ...

BOROUGH PARK — MAIMONIDES CANCER CENTER HAS LAUNCHED A POWERFUL new technology and approach to standard radiation oncology therapy with a state-of-the-art Adaptive Radiation Therapy (ART) system that ...

From Laura Bassi to Marie Curie, for centuries, women have been making important contributions to the world of physics. Now with ViewRay’s MRIdian system, women are leading the charge in bringing the ...

Findings from a recent prospective study show promising safety and patient outcomes data for locally advanced and borderline resectable pancreatic cancer treatment using ablative Stereotactic ...

ProtOnART builds upon the partners’ long-standing research efforts and shared ambition that an online adaptive workflow has the potential to significantly increase the quality of cancer treatments by ...

Findings from a recent prospective study show promising safety and patient outcomes data for locally advanced and borderline resectable pancreatic cancer treatment using ablative Stereotactic ...

The Ethos Clinical Observation Program offers radiation oncology professionals a unique opportunity to gain firsthand experience in the implementation and execution of online adaptive radiation ...

A study co-led by researchers at Miami Cancer Institute, part of Baptist Health South Florida, found that ablative stereotactic magnetic resonance (MR)-guided adaptive radiation therapy may improve ...

Metronomic oral cyclophosphamide as maintenance therapy in metastatic pancreatic ductal adenocarcinoma. This is an ASCO Meeting Abstract from the 2023 ASCO Gastrointestinal Cancers Symposium. This ...